We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.
Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.
Aurigene Pharmaceutical Services Ltd. is a globally recognized contract research, development, and manufacturing organization (CDMO) that actively contributes to the advancement of pharmaceutical innovation. With a steadfast commitment to thought leadership, we offer comprehensive and integrated solutions to empower visionary companies in expediting their products from laboratory to market.
At Aurigene, we seamlessly blend our extensive knowledge, experience, and cutting-edge technology to catalyze the progress of our clients' groundbreaking endeavours. Our unwavering dedication to innovation is underscored by our world-class research and development centres in India, boasting a team of over 650 exceptional scientists. These centres are fortified by state-of-the-art commercial manufacturing facilities strategically located in India, the United Kingdom, Mexico, and the United States.
Aurigene Pharmaceutical Services provides a wide range of high-quality and flexible scale development and manufacturing services for Biotherapeutics and Viral vectors. We are expanding our Biotherapeutics services, with a focus on mono-clonal antibodies(mAbs), therapeutic proteins and viral vectors. We are developing a facility which will meet the process development and clinical supplies needs of global biotech companies. The new facility is based on a state-of-the-art design concept, allowing maximum flexibility for a multi-product, multi-platform offering across proteins, mAbs, and viral vectors. We offer exclusive access to an established large-scale GMP manufacturing facility with a drug substance capacity of 15kl and fill-finish capabilities making it possible to provide commercial quantities seamlessly.
You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.
If you wish to continue to this external website, click Proceed.
October 24th-26th, 2023 | Barcelona, Spain
Get ready to accelerate your drug’s journey to the market